Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
PCL HA Injections
Ingredient: Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml
Specification: 1ml
Package: Single package
Application Area: Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection.
Product Introduction：
Our product features a higher elastic modulus, superior viscoelasticity, and enhanced shaping effects, ensuring a more stable fill with minimal displacement. It contains a higher HA concentration, offers a wider range of options, and can be customized based on user needs. Different models are available to suit various injection areas and purposes, delivering a more natural effect. With prolonged durability, the degradation rate depends on the microsphere type, with polycaprolactone (PCL) microspheres lasting longer than block copolymer microspheres. Its broad applicability extends to the nose, jawline, tear troughs, temples, and more.
Product Display：
Product Details:
Type | PCL-HA Filler |
Ingredient | Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml |
Specification | 1ml |
Effect area | The deep dermis, superficial subcutaneous and deep layers were filled by injection |
Application area | Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12 months |
Microsphere size | The median particle size was 32±6μm, and more than 95% of the microspheres were between 25 and 50μm |
Product Package:
Customer Feedback：
Raw Material Advantages：
With an injection force of just 12N, compared to the conventional 20N, this formulation makes the procedure easier and more efficient for doctors and patients alike. Its high viscoelasticity enhances facial features such as the nasal base, brow ridge, and outer contours. The HA content varies between 20-24 mg/g, offering a wider selection and customization options. The type of microspheres used affects the degradation rate, with PCL microspheres lasting longer than block copolymer microspheres, ensuring extended effectiveness. It is suitable for a range of applications, including enhancements to the nose, jawline, tear troughs, and temples.
Development Process:
Company Introduction:
With low tin content (Sn <30 ppm), adjustable molecular weight, and medical-grade biocompatibility, our PCL/PLLA synthesis process is supported by proprietary synthesis equipment designed for anhydrous, oxygen-free, kilogram-scale production. Additionally, our medical-grade raw material purification technology refines industrial-grade substances into sterile, pyrogen-free materials, including polysaccharides like sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.
